These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32830340)

  • 1. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
    Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
    Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
    Hobson-Peters J; Amarilla AA; Rustanti L; Marks DC; Roulis E; Khromykh AA; Modhiran N; Watterson D; Reichenberg S; Tolksdorf F; Sumian C; Seltsam A; Gravemann U; Faddy HM
    Transfusion; 2023 Feb; 63(2):288-293. PubMed ID: 36573801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
    Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Prow NA; Watterson D; Hall RA; Young PR; Reichenberg S; Sumian C; Faddy HM
    Transfusion; 2016 Sep; 56(9):2278-85. PubMed ID: 27456861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light.
    Praditya D; Friesland M; Gravemann U; Handke W; Todt D; Behrendt P; Müller TH; Steinmann E; Seltsam A
    Vox Sang; 2020 Oct; 115(7):555-561. PubMed ID: 32383163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis E virus is effectively inactivated by methylene blue plus light treatment.
    Gravemann U; Engelmann M; Kinast V; Burkard T; Behrendt P; Schulze TJ; Todt D; Steinmann E
    Transfusion; 2022 Nov; 62(11):2200-2204. PubMed ID: 36125237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. West Nile and Usutu viruses are efficiently inactivated in platelet concentrates by UVC light using the THERAFLEX UV-Platelets system.
    Gravemann U; Boelke M; Könenkamp L; Söder L; Maurer M; Ziegler U; Schulze TJ; Seltsam A; Becker SC; Steffen I
    Vox Sang; 2024 Aug; 119(8):827-833. PubMed ID: 38699884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Prow NA; Watterson D; Young PR; Hall RA; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2016 Jun; 56(6 Pt 2):1548-55. PubMed ID: 26926832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
    Reichenberg S; Gravemann U; Sumian C; Seltsam A
    Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update.
    Seghatchian J; Tolksdorf F
    Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
    Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
    Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial inactivation of platelet concentrates with the THERAFLEX UV-Platelets pathogen inactivation system.
    Gravemann U; Handke W; Müller TH; Seltsam A
    Transfusion; 2019 Apr; 59(4):1324-1332. PubMed ID: 30588633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality.
    Gravemann U; Handke W; Sumian C; Alvarez I; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2018 May; 113(4):368-377. PubMed ID: 29484670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet C light efficiently inactivates nonenveloped hepatitis A virus and feline calicivirus in platelet concentrates.
    Gravemann U; Handke W; Lambrecht B; Schmidt JP; Müller TH; Seltsam A
    Transfusion; 2018 Nov; 58(11):2669-2674. PubMed ID: 30267410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates.
    van der Meer PF; Gravemann U; de Korte D; Sumian C; Tolksdorf F; Müller TH; Seltsam A
    Vox Sang; 2016 Aug; 111(2):127-34. PubMed ID: 27167507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentrates.
    Kim S; Handke W; Gravemann U; Döscher A; Brixner V; Müller TH; Seltsam A
    Transfusion; 2018 Mar; 58(3):758-765. PubMed ID: 29282743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.